"Concise industry news from the US pharmaceutical industry..."
New Account

The Magazine

Issue 11

E-magazine
  • Previous Issues

Blog

Spencer Green
Chairman, GDS International

Sales and the 'Talent Magnet'

A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?
25 May 2011

Company Profile: Catalent Pharma Solutions

Catalent Pharma Solutions | www.catalent.com

No Comments

Development

Catalent offers a full range of development services, such as pre-clinical support, API development, analytical services, drug delivery development, clinical manufacturing and packaging services. We have expertise in inhalation development, and can offer innovative biologic cell-line development using our proprietary GPEx™ technology.

Drug Delivery

We are the world leader in drug delivery systems. Our technologies include: soft gelatin and Vegicaps® Soft capsules; Zydis® fast dissolve dosage form; oral modified-release technologies, including EnCirc®, EnVel®, and EnSolv®; and a range of inhaled technologies.

Manufacturing

We provide manufacturing for nearly every major dose form on the market today. Along with our proprietary dose forms, we also manufacture traditional oral, sterile, topical and inhaled dose forms. We also produce biologics for pre-clinical and clinical studies.

Packaging

Catalent is the largest provider of packaging services to the pharmaceutical industry. Globally positioned, our packaging services include commercial packaging for all dose forms and the supply of printed components. We specialize in new product launch support and are the recognized leader in the packaging of biotechnology products, and the design and development of innovative compliance packaging and novel unit-dose formats. Our award winning proprietary designs include RxBarrier* Plus for oral solid medications, DelPouch® for liquids and creams, and DelStrip* for thin filmstrips.

Catalent. Reliable Solutions. Inspired Results.


More like this...

  • Survive and Thrive

    Four years ago it looked like Schering-Plough might not survive the patent loss of Claritin. Twelve consecutive quarters of adjusted sales growth and substantial R&D...
    Read more
  • New Business Value

    Giles Day, Senior Director of the Targets and Mechanisms Informatics Group, Pfizer explains the three areas that he is focusing on to become more...

    Read more
  • Translational Research and Biomarkers

    Dominic Spinella, Head of Translational Medicine for Pfizer Oncology, explains the concept and how this new research will help pharma move forward.
    Read more
  • Prioritization of Vaccines

    At the September 2007 NGP Discovery & Development Summit in Arizona,Anthony Ford-Hutchinson led a fascinating workshop on the prioritization of...

    Read more
  • Ambition and More

    Dr. Thomas Chan, SVP of Discovery and Development at ArQule gives NGP his insight into what a small biotechnology company are concentrating on in the...

    Read more
  • Moving Clinical Trials Forward

    Dr. Richard Polisson is one busy man. As well as being the Senior Vice President of Clinical Research for Genzyme, overseeing the design and implementation of clinical...

    Read more
Disclaimer: All comments posted in a personal capacity
POST A COMMENT
In order to post a comment you need to be regsitered and signed in.
Register | Sign in
No Comments Have Been Submitted
Disclaimer: All comments posted in a personal capacity